Dabigatran for anticoagulation in atrial fibrillation–early clinical experience in a hospital population and comparison to trial data

J Michel, D Mundell, T Boga, A Sasse - Heart, Lung and Circulation, 2013 - Elsevier
BACKGROUND: Dabigatran is a recently introduced direct thrombin inhibitor licensed for
use as an oral anticoagulant for stroke prevention in non-valvular atrial fibrillation. Our …
被引用次数：29 相关文章

Dabigatran for Anticoagulation in Atrial Fibrillation–Early Clinical Experience in a Hospital Population and Comparison to Trial Data

J Michel, D Mundell, T Boga, A Sasse - Heart, Lung and Circulation, 2013 - infona.pl
Dabigatran is a recently introduced direct thrombin inhibitor licensed for use as an oral
anticoagulant for stroke prevention in non-valvular atrial fibrillation. Our prospective …

Dabigatran for anticoagulation in atrial fibrillation-early clinical experience in a hospital population and comparison to trial data

J Michel, D Mundell, T Boga… - Heart, lung & …, 2013 - pubmed.ncbi.nlm.nih.gov
Background Dabigatran is a recently introduced direct thrombin inhibitor licensed for use as
an oral anticoagulant for stroke prevention in non-valvular atrial fibrillation. Our prospective …

Dabigatran for Anticoagulation in Atrial Fibrillation–Early Clinical Experience in a Hospital Population and Comparison to Trial Data

J Michel, D Mundell, T Boga… - Heart, Lung and Circulation, 2013 - heartlungcirc.org
Background Dabigatran is a recently introduced direct thrombin inhibitor licensed for use as
an oral anticoagulant for stroke prevention in non-valvular atrial fibrillation. Our prospective …

Dabigatran for anticoagulation in atrial fibrillation-early clinical experience in a hospital population and comparison to trial data.

J Michel, D Mundell, T Boga, A Sasse - Heart, Lung & Circulation, 2012 - europepmc.org
Background Dabigatran is a recently introduced direct thrombin inhibitor licensed for use as
an oral anticoagulant for stroke prevention in non-valvular atrial fibrillation. Our prospective …